Methods for Protein Expression in Mammalian Cells in Serum-Free Medium
AssigneeImmunomedics, Inc.
InventorsDavid M. Goldenberg, Chien-Hsing Chang, Edmund A. Rossi, Diane Nordstrom
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmunomedics, Inc.
InventorsDavid M. Goldenberg, Chien-Hsing Chang, Edmund A. Rossi, Diane Nordstrom
Estimating the term…
Disclosed are compositions and methods for increasing the longevity of a cell culture and permitting the increased production of proteins, preferably recombinant proteins, such as antibodies, peptides, enzymes, growth factors, interleukins, interferons, hormones, and vaccines. Cells transfected with an apoptosis-inhibiting gene or vector, such as a triple mutant Bcl-2 gene, can survive longer in culture, resulting in extension of the state and yield of protein biosynthesis. Such transfected cells exhibit maximal cell densities that equal or exceed the maximal density achieved by the parent cell lines. Transfected cells can also be pre-adapted for growth in serum-free medium, greatly decreasing the time required to obtain protein production in serum-free medium. In certain methods, the pre-adapted cells can be used for protein production following transfection under serum-free conditions. In preferred embodiments, the cells of use are SpESF or SpESF-X cells.
A mammalian cell line comprising a gene encoding a mutant Bcl-2 protein, said protein comprising T69E, S70E and S87E amino acid substitutions, the cell line pre-adapted to grow in serum-free medium, the cell line capable of transfection under serum-free conditions with one or more expression vectors expressing a protein of interest and of producing said protein of interest under serum-free conditions.
Dependencies are inferred from the claim text.